MX9803206A - Empleo de epinastina para el tratamiento de dolores. - Google Patents

Empleo de epinastina para el tratamiento de dolores.

Info

Publication number
MX9803206A
MX9803206A MX9803206A MX9803206A MX9803206A MX 9803206 A MX9803206 A MX 9803206A MX 9803206 A MX9803206 A MX 9803206A MX 9803206 A MX9803206 A MX 9803206A MX 9803206 A MX9803206 A MX 9803206A
Authority
MX
Mexico
Prior art keywords
epinastine
pain
treatment
myalgia
bing
Prior art date
Application number
MX9803206A
Other languages
English (en)
Other versions
MXPA98003206A (es
Inventor
Birgit Jung
Christopher John Montagu Meade
Michael Pairet
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of MX9803206A publication Critical patent/MX9803206A/es
Publication of MXPA98003206A publication Critical patent/MXPA98003206A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invencion se refiere al empleo de epinastina como medicamento para el tratamiento de dolores, en particular de migraña, síndrome de Bing-Horton, dolores de cabeza por tension, dolores musculares, dolores inflamatorios o neuralgias.
MXPA/A/1998/003206A 1995-11-14 1998-04-23 Empleo de epinastina para el tratamiento de dolores MXPA98003206A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19542281A DE19542281C2 (de) 1995-11-14 1995-11-14 Verwendung von Epinastin für die Behandlung der Migräne
DE19542281.3 1995-11-14

Publications (2)

Publication Number Publication Date
MX9803206A true MX9803206A (es) 1998-09-30
MXPA98003206A MXPA98003206A (es) 1998-11-16

Family

ID=

Also Published As

Publication number Publication date
HK1015280A1 (en) 1999-10-15
NZ322467A (en) 2000-01-28
AU706112B2 (en) 1999-06-10
JP4264850B2 (ja) 2009-05-20
ATE213160T1 (de) 2002-02-15
EE03512B1 (et) 2001-10-15
RU2238733C2 (ru) 2004-10-27
IL123601A0 (en) 1998-10-30
JP2000500446A (ja) 2000-01-18
CO4770978A1 (es) 1999-04-30
ES2171746T3 (es) 2002-09-16
US5942503A (en) 1999-08-24
UY24354A1 (es) 2001-10-25
ZA969520B (en) 1997-05-14
EP0861081A1 (de) 1998-09-02
CZ290115B6 (cs) 2002-06-12
HU225759B1 (en) 2007-08-28
BG62511B1 (bg) 2000-01-31
BG102408A (en) 1998-12-30
WO1997017971A1 (de) 1997-05-22
BR9611502A (pt) 1999-03-02
DK0861081T3 (da) 2002-05-27
IL123601A (en) 2002-12-01
EP0861081B1 (de) 2002-02-13
DE19542281A1 (de) 1997-05-15
KR19990067527A (ko) 1999-08-25
RU2217144C2 (ru) 2003-11-27
EE9800158A (et) 1998-12-15
RO118373B1 (ro) 2003-05-30
PT861081E (pt) 2002-06-28
JP2009019050A (ja) 2009-01-29
CZ149898A3 (cs) 1998-10-14
PL326653A1 (en) 1998-10-12
KR100435611B1 (ko) 2005-01-13
JP4850880B2 (ja) 2012-01-11
CA2232008C (en) 2004-01-06
NO982172L (no) 1998-05-13
AR004321A1 (es) 1998-11-04
TR199800853T2 (xx) 1998-09-21
CA2232008A1 (en) 1997-05-22
TW575423B (en) 2004-02-11
DE19542281C2 (de) 1997-12-04
CN1202111A (zh) 1998-12-16
NO982172D0 (no) 1998-05-13
SK61398A3 (en) 1998-09-09
HUP9903489A2 (hu) 2000-03-28
PL186615B1 (pl) 2004-02-27
HUP9903489A3 (en) 2001-12-28
DE59608738D1 (de) 2002-03-21
CN1104242C (zh) 2003-04-02
AU7623096A (en) 1997-06-05

Similar Documents

Publication Publication Date Title
CA2232008A1 (en) Use of epinastine for the treatment of pain
MX9705235A (es) Inhibidores de calpaina y/o catepsina b de oxazolidina substituida.
AP1401A (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic- depressive bipolar disorder.
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
LV11615A (lv) Amidi ar arstnieciskam ipasibam
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
PL335254A1 (en) Methods of treating vomiting and central nervous system disorders by means ogf(+) norcisapride
MX9707613A (es) Citostaticos modificados con hidratos de carbono.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
NO975545D0 (no) Cellelinje som produserer analgetiske forbindelser for behandling av smerte
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
NO982562D0 (no) Sammensetning for behandling av smerte
AUPP379698A0 (en) Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
NZ328198A (en) a pharmaceutical composition containing hydroxyzine and a serotonin uptake inhibitor
HUP0003023A3 (en) (s) 2-methylamino-2-phenyl-n-butyl 3,4,5-trimethoxybenzoate, its application to the treatment of chronic pain
IT1284920B1 (it) Trattamento del diamante
DE69631838D1 (de) Verkleidung, miteinander verbundene naturstein-halterungseinheiten und naturstein-halterungseinheit
ITRM930154A0 (it) Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
BR9301992A (pt) Brinco com extremidade energética para efeito de acupuntura
EA199800818A1 (ru) Способ лечения бессонницы
TW338026B (en) Fluid treatment system